| The Efficacy and Safety of Nab-paclitaxel Plus S-1 in First-line Treatment of Advanced Biliary Tract Adenocarcinoma (NCT03830606) | Aiping Zhou | 2016-03-23 |
| Clinical Study to Evaluate the Efficacy of HUDC_VT in Patients With Bacterial Vaginosis (NCT03357666) | Haudongchun Co., Ltd. | 2016-03-22 |
| Aminolaevulinic Acid Photodynamic Therapy for HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1) (NCT02631863) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2016-03-22 |
| A Study to Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis (RA) Who Are on a Stable Dose of Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) and Have an Inadequate Response to csDMARDs (NCT02720523) | AbbVie | 2016-03-22 |
| Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC) (NCT02638090) | H. Lee Moffitt Cancer Center and Research Institute | 2016-03-22 |
| Androgen Deprivation Therapy, External Beam Radiotherapy and Stereotactic Radiosurgery Boost for Prostate Cancer (NCT03322020) | Asan Medical Center | 2016-03-21 |
| Efficacy and Safety of Inhaled Molgramostim (rhGM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis (NCT02702180) | Savara Inc. | 2016-03-21 |
| Eosinophilic Esophagitis Intervention Trial-1 Food vs. 4 Food Elimination Diet Followed by Swallowed Glucocorticoids (NCT02610816) | Children's Hospital Medical Center, Cincinnati | 2016-03-21 |
| Testing GSK2636771 as a Potential Targeted Treatment in Cancers With PTEN Loss of Expression (MATCH-Subprotocol P) (NCT04439188) | National Cancer Institute (NCI) | 2016-03-21 |
| Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi-Site Phase 2b Clinical Study (NCT02933879) | Sun Pharmaceutical Industries, Inc. | 2016-03-21 |
| A Study Investigating the Effects of Niagen™ in Healthy Adults. (NCT02712593) | KGK Science Inc. | 2016-03-21 |
| Study of the Effects of Pembrolizumab in Patients With Advanced Solid Tumors (NCT02644369) | University Health Network, Toronto | 2016-03-21 |
| Lirilumab and Nivolumab With 5-Azacitidine in Patients With Myelodysplastic Syndromes (MDS) (NCT02599649) | M.D. Anderson Cancer Center | 2016-03-21 |
| Longitudinal MR Imaging of Pulmonary Function in Patients Receiving Thoracic Radiation Treatment (NCT02478255) | Bastiaan Driehuys | 2016-03-21 |
| Topical Erythropoietin Hydrogel Formulation for Diabetic Foot Ulcers (NCT02361931) | Remedor Biomed Ltd | 2016-03-21 |
| A Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate Cancer (NCT02737332) | Sun Pharmaceutical Industries Limited | 2016-03-21 |
| To Compare Efficacy of Low Dose Diclofenac (25mg) in Management of Postoperative Pain After Periodontal Flap Surgery (NCT03519152) | Tatyasaheb Kore Dental College | 2016-03-20 |
| Empa Add on to Insulin in Japanese Patient With Type 1 Diabetes Mellitus (NCT02702011) | Boehringer Ingelheim | 2016-03-20 |
| Afatinib in NSCLC With HER2 Mutation (NCT02597946) | Boehringer Ingelheim | 2016-03-18 |
| Phase II Study of Ramucirumab With Chemotherapy in Patients With Metastatic Gastroesophageal Junction and Gastric Cancer (NCT02726399) | Memorial Sloan Kettering Cancer Center | 2016-03-18 |
| An Investigational Immuno-therapy Trial of Pomalidomide and Low-dose Dexamethasone With or Without Elotuzumab to Treat Refractory and Relapsed and Refractory Multiple Myeloma (ELOQUENT-3) (NCT02654132) | Bristol-Myers Squibb | 2016-03-18 |
| Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in Treating Patients With Chronic Lymphocytic Leukemia (NCT02629809) | M.D. Anderson Cancer Center | 2016-03-18 |
| Clinical Study of Concurrent Pazopanib and Radiotherapy for Non-metastatic Sarcoma Patients (NCT02575066) | The Netherlands Cancer Institute | 2016-03-17 |
| A Study to Investigate the Efficacy and Safety of GSK3196165 in Inflammatory Hand Osteoarthritis (NCT02683785) | GlaxoSmithKline | 2016-03-17 |
| A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors. (NCT02734004) | AstraZeneca | 2016-03-17 |
| A Phase II Trial of Sofosbuvir (SOF) and GS-5816 for People With Chronic Hepatitis C Virus Infection and Recent Injection Drug Use (NCT02336139) | Kirby Institute | 2016-03-16 |
| Randomized Short-term Pre-surgical Study to Assess the Effects of Abemaciclib (LY2835219) in Early Breast Cancer Patients (NCT02831530) | Gustave Roussy, Cancer Campus, Grand Paris | 2016-03-16 |
| Custodiol Versus Blood Cardioplegaia in Paediatric Cardiac Surgery (NCT03082716) | King Faisal Specialist Hospital & Research Center | 2016-03-16 |
| A Study of Intermittent Dosing Schedule of Imatinib in Patients With Tyrosine Kinase Inhibitor Refractory GISTs (NCT02712112) | Asan Medical Center | 2016-03-16 |
| A Study Using Tumor-Reactive Autologous Tumor Infiltrating Lymphocytes (TIL) in Metastatic Melanomas (NCT02375984) | Saint John's Cancer Institute | 2016-03-16 |
| Efficacy and Safety Study of a IMSS Developed Phytopharmaceutical for the Treatment of Anxiety. (NCT03702803) | Coordinación de Investigación en Salud, Mexico | 2016-03-16 |
| Metformin in Moderate and Severe Renal Failure (CKD 3-4): A Follow-up Study (NCT02848508) | Centre Hospitalier Universitaire, Amiens | 2016-03-16 |
| Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7 (NCT02601014) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-03-15 |
| Cayenne Pepper Cataplasm - Safety Study (NCT03440125) | University of Primorska | 2016-03-15 |
| Estrogen Replacement in Anorexia Nervosa (NCT03172533) | University of Erlangen-Nürnberg Medical School | 2016-03-15 |
| A Phase II Study of SGI-110 in Philadelphia-Negative Myeloproliferative Neoplasms (NCT03075826) | Weill Medical College of Cornell University | 2016-03-15 |
| Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is Recurrent (NCT02568449) | Barbara Ann Karmanos Cancer Institute | 2016-03-15 |
| Sym004 in Combination With FOLFIRI in Metastatic Colorectal Cancer Patients (NCT02568046) | Symphogen A/S | 2016-03-15 |
| Study on the Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Participants With Osteomyelitis (NCT02685033) | Durata Therapeutics Inc., an affiliate of Allergan plc | 2016-03-15 |
| PERSEUS: Preliminary Efficacy and Safety of Cenicriviroc in Adult Participants With Primary Sclerosing Cholangitis (NCT02653625) | Tobira Therapeutics, Inc. | 2016-03-14 |
| TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer (NCT02693535) | American Society of Clinical Oncology | 2016-03-14 |
| Alvocidib Biomarker-driven Phase 2 AML Study (NCT02520011) | Sumitomo Pharma America, Inc. | 2016-03-14 |
| Comparison of Systematic Surgery Versus Surveillance and Rescue Surgery in Operable Oesophageal Cancer With a Complete Clinical Response to Radiochemotherapy (NCT02551458) | Centre Hospitalier Universitaire Dijon | 2016-03-14 |
| BM-MNC and UCMSC for Type 2 Diabetes Mellitus Patients (NCT04501341) | Indonesia University | 2016-03-14 |
| Study of the Efficacy and Safety of BP101 in Female Patients With Decrease or Loss of Sexual Desire (NCT03080298) | Ivix LLX | 2016-03-14 |
| GutHeart: Targeting Gut Microbiota to Treat Heart Failure (NCT02637167) | Oslo University Hospital | 2016-03-11 |
| Study of Apatinib in Patients With Differentiated Thyroid Cancer (NCT02731352) | Peking Union Medical College Hospital | 2016-03-11 |
| An Open-label Extension Study to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol (NCT02564952) | Jazz Pharmaceuticals | 2016-03-11 |
| ER Reactivation Therapy for Breast Cancer (NCT02188745) | Dartmouth-Hitchcock Medical Center | 2016-03-11 |
| Long-Term Assessment of Remyelinating Therapy (NCT02657915) | Biogen | 2016-03-10 |
| Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721 (NCT02682407) | Omeros Corporation | 2016-03-10 |
| Reirradiation With Pembrolizumab in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and Neck (NCT02289209) | Dan Zandberg | 2016-03-09 |
| Effects of Botulinum Toxin Injections in Patients With Hereditary Spastic Paraplegia (NCT02604186) | University of Campinas, Brazil | 2016-03-09 |
| A Study of Obinutuzumab, Rituximab, Polatuzumab Vedotin, and Venetoclax in Relapsed or Refractory Follicular Lymphoma (FL) or Diffuse Large B-Cell Lymphoma (DLBCL) (NCT02611323) | Hoffmann-La Roche | 2016-03-09 |
| Safety, Tolerability, and Efficacy of MN-001 (Tipelukast) in Patients With Idiopathic Pulmonary Fibrosis (NCT02503657) | MediciNova | 2016-03-09 |
| Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD) (NCT02592798) | Bristol-Myers Squibb | 2016-03-09 |
| Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors (NCT02689219) | Nabil Adra | 2016-03-09 |
| An Open-Label, Phase Ib/II Clinical Trial Of Cdk 4/6 Inhibitor, Ribociclib (Lee011), In Combination With Trastuzumab Or T-Dm1 For Advanced/Metastatic Her2-Positive Breast Cancer. (NCT02657343) | Dana-Farber Cancer Institute | 2016-03-09 |
| Simvastatin as a Neuroprotective Treatment for Moderate Parkinson's Disease (NCT02787590) | University Hospital Plymouth NHS Trust | 2016-03-08 |
| Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin (NCT02535312) | National Cancer Institute (NCI) | 2016-03-08 |
| A Study of ACP-196 (Acalabrutinib) in Subjects With Relapsed/Refractory CLL and Intolerant of Ibrutinib Therapy (NCT02717611) | Acerta Pharma BV | 2016-03-08 |
| Safety and Efficacy of CRS-207 With Epacadostat in Platinum Resistant Ovarian, Fallopian or Peritoneal Cancer (NCT02575807) | Aduro Biotech, Inc. | 2016-03-08 |
| HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib (NCT03850366) | Henry Ford Health System | 2016-03-08 |
| Comparison of Two Methods of Administration of the Epidural, by Programmed Intermittent Bolus or Continuous Perfusion, on the Incidence of Cesarean Sections and Instrumented Deliveries in Primiparous Women (NCT02705872) | Brugmann University Hospital | 2016-03-08 |
| Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke (NCT02448641) | SanBio, Inc. | 2016-03-08 |
| A Safety, Tolerability and Preliminary Efficacy Study of BBI-4000 Gel in Subjects With Palmar Hyperhidrosis (NCT02682238) | Botanix Pharmaceuticals | 2016-03-08 |
| Study of Lumasiran in Healthy Adults and Patients With Primary Hyperoxaluria Type 1 (NCT02706886) | Alnylam Pharmaceuticals | 2016-03-08 |
| A Study Evaluating the Safety and Efficacy of Brexucabtagene Autoleucel (KTE-X19) in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-3) (NCT02614066) | Kite, A Gilead Company | 2016-03-07 |
| A Study to Evaluate Clinical Effect, Pharmacokinetics , Safety, and Tolerability of Umeclidinium in Palmar Hyperhidrosis Subjects (NCT02673619) | Stiefel, a GSK Company | 2016-03-07 |
| Motivated Behavior in Adults With and Without ADHD (NCT02630017) | University of Arkansas | 2016-03-07 |
| Study 3: Minocycline Decreases Microglia Activation (NCT02213575) | University of Florida | 2016-03-05 |
| A Study to Evaluate the Efficacy and Safety of Fixed Dose Combination of DW340 in Patients With Acute Low Back Pain (NCT03424707) | Daewon Pharmaceutical Co., Ltd. | 2016-03-04 |
| Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma (NCT02611037) | H. Lee Moffitt Cancer Center and Research Institute | 2016-03-04 |
| Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) Prevention (NCT02588339) | H. Lee Moffitt Cancer Center and Research Institute | 2016-03-04 |
| Effects of Switching From ATRIPLA™ (Efavirenz, Tenofovir, Emtricitabine) to MK-1439A (Doravirine, Tenofovir, Lamivudine) in Virologically-Suppressed Participants (MK-1439A-028) (NCT02652260) | Merck Sharp & Dohme LLC | 2016-03-04 |
| Phase 2a Study to Evaluate the Safety and Efficacy of PH100 Tablet in T2DM Patients With Recent Cardiovascular (NCT04141241) | Bota Bio Co., Ltd. | 2016-03-04 |
| Apatinib in Recurrent or Refractory Intracranial Central Nervous System Malignant Tumors (NCT03660761) | Rongjie Tao | 2016-03-03 |
| Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations (NCT02687542) | Pfizer | 2016-03-03 |
| Impact of a Booster Course of Antenatal Steroids on Neonatal Outcome in Patients With Premature Rupture of the Membranes (NCT02469519) | Pediatrix | 2016-03-03 |
| Repurposing Anti-TNF for Treating Dupuytren's Disease (NCT03180957) | University of Oxford | 2016-03-02 |
| Immunogenicity of a Quadrivalent Virus-Like Particles (VLP) Influenza Vaccine in Healthy Adults (NCT02768805) | Medicago | 2016-03-02 |
| Study of Mirvetuximab Soravtansine in Combination With Bevacizumab, Carboplatin, Pegylated Liposomal Doxorubicin, Pembrolizumab, or Bevacizumab + Carboplatin in Participants With Folate Receptor Alpha (FRα) Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal, or Fallopian Tube Cancer (NCT02606305) | ImmunoGen, Inc. | 2016-03-02 |
| A Three Part Study of MGV354 in Ocular Hypertension or Glaucoma (NCT02743780) | Alcon Research | 2016-03-02 |
| Anti-vasculaR Endothelial Growth Factor plUs Anti-angiopoietin 2 in Fixed comBination therapY: Evaluation for the Treatment of Diabetic Macular Edema (NCT02712008) | Regeneron Pharmaceuticals | 2016-03-02 |
| Study to Evaluate Safety, Tolerability and Efficacy of UCB7665 in Subjects With Primary Immune Thrombocytopenia (NCT02718716) | UCB Biopharma SRL | 2016-03-02 |
| Effects of GLP-1 Analogues on Fluid Intake in Patients With Primary Polydipsia (The GOLD-Study) (NCT02770885) | University Hospital, Basel, Switzerland | 2016-03-01 |
| An Open Label, Single-Centre, Pilot Study of Everolimus With EBRT for the Treatment of mNET Liver Metastasis (NCT02205515) | Sunnybrook Health Sciences Centre | 2016-03-01 |
| Ixazomib & Rituximab After Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma in Remission (NCT02632396) | Emory University | 2016-03-01 |
| A Phase 2 Study of a Subcutaneous Injection of TAK-850 in Healthy Adult Participants (NCT02713061) | Takeda | 2016-03-01 |
| Fecal Microbiota Transplantation for Severe Clostridium Difficile Infection (NCT03427229) | Catholic University of the Sacred Heart | 2016-03-01 |
| Contrast Enhanced Ultrasound for Evaluation of Reflux Nephropathy (NCT02786810) | University of Tennessee | 2016-03-01 |
| Incretin-based Therapy in Early Diagnosed Type 1 Diabetes (NCT02908087) | University of Oulu | 2016-03-01 |
| A Study of Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast Cancer (NCT02685306) | Peregrine Pharmaceuticals | 2016-03-01 |
| Esophageal Stent Migration With Endoscopic Suture Fixation Compared to Standard Deployment (NCT02751333) | Johns Hopkins University | 2016-03-01 |
| Safety and Immunogenicity of the Dengue Virus Vaccine TV005 (TetraVax-DV TV005) in Healthy Adults, Adolescents, and Children in Dhaka, Bangladesh (NCT02678455) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-03-01 |
| Phase II Study Testing the Tolerability and the Efficacy of Bosutinib in Chronic Phase CML Patients (NCT03205267) | University of Bonn | 2016-03-01 |
| A Study of Type-1 Polarized Dendritic Cell (αDC1) Vaccine in Combination With Tumor-Selective Chemokine Modulation (Interferon-α2b, Rintatolimod, and Celecoxib) in Subjects With Chemo-Refractory Metastatic Colorectal Cancer (NCT02615574) | Pawel Kalinski | 2016-03-01 |
| Pembrolizumab Plus Docetaxel for the Treatment of Recurrent or Metastatic Head and Neck Cancer (NCT02718820) | Medical University of Vienna | 2016-03-01 |
| Optimal Sequencing of Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in First-Line NSCLC (NCT02591615) | Alliance Foundation Trials, LLC. | 2016-03-01 |
| Efficacy of Transcutaneous Nerve Stimulation on Improvement of Overactive Bladder Symptoms (NCT02110680) | Meir Medical Center | 2016-03-01 |